Neoadjuvant Imiquimod Immunotherapy for Oral Cancer
NCT04883645
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Oral Squamous Cell Carcinoma
Interventions
DRUG:
Imiquimod 5% Cream
Sponsor
Medical University of South Carolina
Collaborators
[object Object]